reviewThe Lancet OncologyMay 31, 2016GREEN OA

Antibody–drug conjugates for cancer therapy

ATAnish ThomasBABeverly A. TeicherRHRaffit Hassan

National Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

581
total citations
FWCI
23.27
Percentile
100%
References
84
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Brentuximab vedotin
  • Monoclonal antibody
  • Medicine
  • Antibody-drug conjugate
  • Antibody
  • Drug
  • Cytotoxic T cell
  • Immunotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.